Tether Freezes 22 Wallets Across Ethereum and Tron

TheCryptoTimesPubblicato 2025-10-17Pubblicato ultima volta 2025-10-17

Tether, the company behind the popular stablecoin USDT, has frozen $13.4 million worth of USDT spread across 22 wallets on the Ethereum and Tron networks. 

Blockchain tracking firm MistTrack reported that the largest share of the frozen funds, $10.3 million, was held in a single Ethereum address ‘0xecbd8…’. Another wallet ‘TYzDebk…’ on Tron contained USDT worth approximately $1.4 million.

The company has carried out similar actions throughout the year. In June, it froze more than $12.3 million, and in April 2025, around 28.67 million USDT was frozen across 13 wallets. 

In March, Tether froze $28 million in USDT on the Russian crypto exchange Garantex, though blockchain analysis firm Global Ledger noted that the exchange still held $15 million in active funds.

In a September 15 statement, Tether said it has frozen over $3.2 billion in USDT connected to criminal activity, working with more than 290 law enforcement agencies in 59 countries. Over the past year, the company has blocked around 3,660 wallets.

Why the wallets are frozen

Tether usually freezes wallets when requested by authorities like the U.S. Department of Justice (DOJ), the Federal Bureau of Investigation (FBI), or other international agencies. 

Wallets linked to fraud, terrorism, sanctioned entities, or illegal markets may be blocked to stop the movement of funds. The company also keeps an eye on blockchain activity to follow anti-money-laundering and sanctions rules.

Not everyone agrees with Tether’s approach. Recently, Texas-based Riverstone Consulting filed a lawsuit, claiming the company wrongly froze $44.7 million in April, which affected their investments. Riverstone says Tether skipped formal international procedures, including the Bulgarian International Judicial Assistance Treaty, which requires requests to go through official channels.

Also Read: Tether Donates $250K to OpenSats for Bitcoin Ecosystem Growth


Mobile Only ImageMobile Only Image

Crypto di tendenza

Letture associate

JPMorgan Research Report Analysis: Moderna's INT Trial Meets Endpoints, but Market Already Priced In

On August 19, J.P. Morgan (JPM) published a research report analyzing Moderna's recent Phase III trial success for its Individualized Neoantigen Therapy (INT), developed in partnership with Merck, in adjuvant melanoma. The trial met its primary endpoint of significantly improved recurrence-free survival and the key secondary endpoint of distant metastasis-free survival. While JPM acknowledged the strong clinical value of these results, particularly the prevention of distant metastasis, the bank stated that this success was widely anticipated, with an 85% prior probability of success, and is already reflected in Moderna's current market valuation. Following the announcement, Moderna's stock rose in pre-market trading. However, JPM maintained its Underweight rating and $40 price target, implying approximately 36% downside from the current price of ~$63. The core rationale is that the success in adjuvant melanoma, a relatively small market in immuno-oncology, is fully priced in. Moderna's future valuation hinges entirely on INT's ability to demonstrate similar efficacy across broader cancer indications. JPM's valuation model incorporates only a modest risk-adjusted value (~$3/share) for the melanoma approval. Approximately $15/share of its target price is attributed to INT's potential in other cancer types. The report identifies upcoming data readouts in non-melanoma cancers (e.g., lung, head & neck, renal) as the critical variable that will determine the platform's ultimate value. Upside risks include better-than-expected data in these new indications, while downside risks involve clinical failures, regulatory delays, or commercial underperformance. In conclusion, JPM views the pre-market stock move as driven by short covering and trading sentiment rather than a fundamental re-rating. The bank remains bearish, arguing that Moderna must now prove INT's efficacy as a platform technology beyond melanoma to justify its current market cap.

marsbit43 min fa

JPMorgan Research Report Analysis: Moderna's INT Trial Meets Endpoints, but Market Already Priced In

marsbit43 min fa

Treasury Department Directly Intervenes to Suppress Long-Term Interest Rates

The article discusses the U.S. Treasury's recent direct intervention to suppress long-term bond yields through buyback operations. While distinct from traditional Yield Curve Control (YCC), this move is interpreted as direct government intervention in its own financing costs. The author emphasizes the short-term tactical nature of this action and contrasts it with the Federal Reserve's upcoming, potentially divergent, policy stance at Jackson Hole. The core issue is framed as a long-term U.S. strategic dilemma: managing high deficit levels. The analysis argues that deficit reduction cannot realistically come from spending cuts or traditional industries, but must rely on achieving higher economic growth driven by technological breakthroughs. Current monetary tightening, while possibly curbing yields and inflation in the short term, is seen as potentially counterproductive to this necessary long-term investment in technology and supply chain resilience. The piece draws historical parallels, placing the current intervention between the 2000-2002 Treasury buybacks (for liquidity) and larger-scale Fed-led "Operation Twist" maneuvers. The effectiveness of the Treasury's action is deemed limited without Federal Reserve cooperation, which would signify a more significant policy shift. Ultimately, the author views such technical, bureaucratic interventions as treating symptoms rather than the underlying disease of the U.S. economy's structural challenges and "K-shaped" divergence. The conclusion suggests that sustained yield suppression by the Fed, combined with specific geopolitical outcomes, could serve as a catalyst for a more profound discussion on broader U.S. and dollar trajectory.

marsbit43 min fa

Treasury Department Directly Intervenes to Suppress Long-Term Interest Rates

marsbit43 min fa

Trading

Spot

Articoli Popolari

Come comprare TRX

Benvenuto in HTX.com! Abbiamo reso l'acquisto di TRON (TRX) semplice e conveniente. Segui la nostra guida passo passo per intraprendere il tuo viaggio nel mondo delle criptovalute.Step 1: Crea il tuo Account HTXUsa la tua email o numero di telefono per registrarti il tuo account gratuito su HTX. Vivi un'esperienza facile e sblocca tutte le funzionalità,Crea il mio accountStep 2: Vai in Acquista crypto e seleziona il tuo metodo di pagamentoCarta di credito/debito: utilizza la tua Visa o Mastercard per acquistare immediatamente TRONTRX.Bilancio: Usa i fondi dal bilancio del tuo account HTX per fare trading senza problemi.Terze parti: abbiamo aggiunto metodi di pagamento molto utilizzati come Google Pay e Apple Pay per maggiore comodità.P2P: Fai trading direttamente con altri utenti HTX.Over-the-Counter (OTC): Offriamo servizi su misura e tassi di cambio competitivi per i trader.Step 3: Conserva TRON (TRX)Dopo aver acquistato TRON (TRX), conserva nel tuo account HTX. In alternativa, puoi inviare tramite trasferimento blockchain o scambiare per altre criptovalute.Step 4: Scambia TRON (TRX)Scambia facilmente TRON (TRX) nel mercato spot di HTX. Accedi al tuo account, seleziona la tua coppia di trading, esegui le tue operazioni e monitora in tempo reale. Offriamo un'esperienza user-friendly sia per chi ha appena iniziato che per i trader più esperti.

1.8k Totale visualizzazioniPubblicato il 2024.12.10Aggiornato il 2026.06.02

Come comprare TRX

Discussioni

Benvenuto nella Community HTX. Qui puoi rimanere informato sugli ultimi sviluppi della piattaforma e accedere ad approfondimenti esperti sul mercato. Le opinioni degli utenti sul prezzo di TRX TRX sono presentate come di seguito.

活动图片